DICE Therapeutics Inc

NASDAQ:DICE   3:59:58 PM EDT
17.69
+0.15 (+0.86%)
Earnings Announcements

DICE Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/21/2022 20:24 GMT
DICE Therapeutics Inc (DICE) - Dice Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights.
Dice Therapeutics Inc - Qtrly Loss per Share $0.44.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.